The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
A phase II study of pemetrexed combined with cisplatin in patients (pts) with recurrent or metastatic nasopharyngeal carcinoma.
A. W. M. Lee
No relevant relationships to disclose
T. K. Yau
No relevant relationships to disclose
T. C. Shum
No relevant relationships to disclose
W. T. Ng
No relevant relationships to disclose
L. L. Chan
No relevant relationships to disclose
R. M. Yeung
No relevant relationships to disclose